J&J COVID-19 Vaccine Rollout Resumes: What to Know

J&J COVID-19 Vaccine Rollout Resumes: What to Know

U.S. federal health officials said on April 23 that the Johnson & Johnson COVID-19 vaccine could restart, with vaccine fact sheets updated to warn of rare blood clot risks. On April 23, the CDC’s Advisory Committee on Immunization Practices (ACIP) looked at the risks and benefits of the J&J vaccine. The CDC identified 15 cases of a rare blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS) in people who had received the J&J vaccine. This is out of nearly 8 million vaccine doses administered in the United States before the CDC and FDA recommended a pause in the use of the vaccine on April 13. The ACIP also looked at the benefits of resuming the J&J vaccine.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!